204 related articles for article (PubMed ID: 30065492)
1. Irreversible Electroporation: A Novel Ultrasound-guided Modality for Non-thermal Tumor Ablation.
Hsiao CY; Huang KW
J Med Ultrasound; 2017; 25(4):195-200. PubMed ID: 30065492
[TBL] [Abstract][Full Text] [Related]
2. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors.
Yun JH; Fang A; Khorshidi F; Habibollahi P; Kutsenko O; Etezadi V; Hunt S; Nezami N
Curr Oncol Rep; 2023 Nov; 25(11):1213-1226. PubMed ID: 37695398
[TBL] [Abstract][Full Text] [Related]
3. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
4. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
Savic LJ; Chapiro J; Hamm B; Gebauer B; Collettini F
Rofo; 2016 Aug; 188(8):735-45. PubMed ID: 27074423
[TBL] [Abstract][Full Text] [Related]
5. New Surgical Approach to Treat Fibroids and Solid Tumors - Thermal and Nonthermal Ablation.
Wong WF
Gynecol Minim Invasive Ther; 2023; 12(4):191-194. PubMed ID: 38034109
[TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation: a new ablation modality--clinical implications.
Rubinsky B; Onik G; Mikus P
Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
[TBL] [Abstract][Full Text] [Related]
7. An overview of the irreversible electroporation for the treatment of liver metastases: When to use it.
Belfiore MP; De Chiara M; Reginelli A; Clemente A; Urraro F; Grassi R; Belfiore G; Cappabianca S
Front Oncol; 2022; 12():943176. PubMed ID: 36119531
[TBL] [Abstract][Full Text] [Related]
8. [Irreversible electroporation: local tumor ablation with systemic immune effect].
Geboers B; Timmer FEF; van den Tol PM; de Gruijl TD; Scheffer HJ; Meijerink MR
Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34854585
[TBL] [Abstract][Full Text] [Related]
9. Irreversible electroporation: state of the art.
Wagstaff PG; Buijs M; van den Bos W; de Bruin DM; Zondervan PJ; de la Rosette JJ; Laguna Pes MP
Onco Targets Ther; 2016; 9():2437-46. PubMed ID: 27217767
[TBL] [Abstract][Full Text] [Related]
10. High-Frequency Irreversible Electroporation: Safety and Efficacy of Next-Generation Irreversible Electroporation Adjacent to Critical Hepatic Structures.
Siddiqui IA; Kirks RC; Latouche EL; DeWitt MR; Swet JH; Baker EH; Vrochides D; Iannitti DA; Davalos RV; McKillop IH
Surg Innov; 2017 Jun; 24(3):276-283. PubMed ID: 28492356
[TBL] [Abstract][Full Text] [Related]
11. [Irreversible electroporation: a new form of image-guided tumour ablation].
Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
[TBL] [Abstract][Full Text] [Related]
12. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
13. Irreversible electroporation: ready for prime time?
Lu DS; Kee ST; Lee EW
Tech Vasc Interv Radiol; 2013 Dec; 16(4):277-86. PubMed ID: 24238383
[TBL] [Abstract][Full Text] [Related]
14. Irreversible electroporation and the pancreas: What we know and where we are going?
Young SJ
World J Gastrointest Surg; 2015 Aug; 7(8):138-44. PubMed ID: 26328033
[TBL] [Abstract][Full Text] [Related]
15. Niche Applications of Irreversible Electroporation.
Bhatia SS; Arya R; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):170-5. PubMed ID: 26365547
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided percutaneous high-frequency irreversible electroporation in porcine livers using four electrode needles: A feasibility and safety study.
Li CT; Zhao GD; Zou WB; Zhang ZH; Zhao Y; Liu R
Cancer Med; 2024 Mar; 13(5):e7035. PubMed ID: 38491833
[TBL] [Abstract][Full Text] [Related]
18. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
Davalos RV; Bhonsle S; Neal RE
Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
20. The effects of irreversible electroporation triggering anti-tumor immunity and the value of its combination with immunotherapy.
Li H; Zhou Y; Guo X; Zhang Q; Ding X
J Interv Med; 2023 Aug; 6(3):107-110. PubMed ID: 37846332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
